224 related articles for article (PubMed ID: 22570503)
1. Choline-releasing glycerophosphodiesterase EDI3 drives tumor cell migration and metastasis.
Stewart JD; Marchan R; Lesjak MS; Lambert J; Hergenroeder R; Ellis JK; Lau CH; Keun HC; Schmitz G; Schiller J; Eibisch M; Hedberg C; Waldmann H; Lausch E; Tanner B; Sehouli J; Sagemueller J; Staude H; Steiner E; Hengstler JG
Proc Natl Acad Sci U S A; 2012 May; 109(21):8155-60. PubMed ID: 22570503
[TBL] [Abstract][Full Text] [Related]
2. EDI3 links choline metabolism to integrin expression, cell adhesion and spreading.
Lesjak MS; Marchan R; Stewart JD; Rempel E; Rahnenführer J; Hengstler JG
Cell Adh Migr; 2014; 8(5):499-508. PubMed ID: 25482527
[TBL] [Abstract][Full Text] [Related]
3. Choline-releasing glycerophosphodiesterase EDI3 links the tumor metabolome to signaling network activities.
Marchan R; Lesjak MS; Stewart JD; Winter R; Seeliger J; Hengstler JG
Cell Cycle; 2012 Dec; 11(24):4499-506. PubMed ID: 23114620
[TBL] [Abstract][Full Text] [Related]
4. Glycerophosphocholine (GPC) is a poorly understood biomarker in breast cancer.
Moestue SA; Giskeødegård GF; Cao MD; Bathen TF; Gribbestad IS
Proc Natl Acad Sci U S A; 2012 Sep; 109(38):E2506; author reply E2507. PubMed ID: 22851771
[No Abstract] [Full Text] [Related]
5. Inhibiting the glycerophosphodiesterase EDI3 in ER-HER2+ breast cancer cells resistant to HER2-targeted therapy reduces viability and tumour growth.
Keller M; Rohlf K; Glotzbach A; Leonhardt G; Lüke S; Derksen K; Demirci Ö; Göçener D; AlWahsh M; Lambert J; Lindskog C; Schmidt M; Brenner W; Baumann M; Zent E; Zischinsky ML; Hellwig B; Madjar K; Rahnenführer J; Overbeck N; Reinders J; Cadenas C; Hengstler JG; Edlund K; Marchan R
J Exp Clin Cancer Res; 2023 Jan; 42(1):25. PubMed ID: 36670508
[TBL] [Abstract][Full Text] [Related]
6. Glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) expression correlates with malignant choline phospholipid metabolite profiles in human breast cancer.
Cao MD; Döpkens M; Krishnamachary B; Vesuna F; Gadiya MM; Lønning PE; Bhujwalla ZM; Gribbestad IS; Glunde K
NMR Biomed; 2012 Sep; 25(9):1033-42. PubMed ID: 22279038
[TBL] [Abstract][Full Text] [Related]
7. EDI3 knockdown in ER-HER2+ breast cancer cells reduces tumor burden and improves survival in two mouse models of experimental metastasis.
Glotzbach A; Rohlf K; Gonscharow A; Lüke S; Demirci Ö; Begher-Tibbe B; Overbeck N; Reinders J; Cadenas C; Hengstler JG; Edlund K; Marchan R
Breast Cancer Res; 2024 May; 26(1):87. PubMed ID: 38816770
[TBL] [Abstract][Full Text] [Related]
8. Molecular Effects of Doxorubicin on Choline Metabolism in Breast Cancer.
Cheng M; Rizwan A; Jiang L; Bhujwalla ZM; Glunde K
Neoplasia; 2017 Aug; 19(8):617-627. PubMed ID: 28654865
[TBL] [Abstract][Full Text] [Related]
9. Interplay of choline metabolites and genes in patient-derived breast cancer xenografts.
Grinde MT; Skrbo N; Moestue SA; Rødland EA; Borgan E; Kristian A; Sitter B; Bathen TF; Børresen-Dale AL; Mælandsmo GM; Engebraaten O; Sørlie T; Marangoni E; Gribbestad IS
Breast Cancer Res; 2014 Jan; 16(1):R5. PubMed ID: 24447408
[TBL] [Abstract][Full Text] [Related]
10. Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells.
Iorio E; Ricci A; Bagnoli M; Pisanu ME; Castellano G; Di Vito M; Venturini E; Glunde K; Bhujwalla ZM; Mezzanzanica D; Canevari S; Podo F
Cancer Res; 2010 Mar; 70(5):2126-35. PubMed ID: 20179205
[TBL] [Abstract][Full Text] [Related]
11. Glycerol-3-phosphate Acyltransferase 1 Promotes Tumor Cell Migration and Poor Survival in Ovarian Carcinoma.
Marchan R; Büttner B; Lambert J; Edlund K; Glaeser I; Blaszkewicz M; Leonhardt G; Marienhoff L; Kaszta D; Anft M; Watzl C; Madjar K; Grinberg M; Rempel E; Hergenröder R; Selinski S; Rahnenführer J; Lesjak MS; Stewart JD; Cadenas C; Hengstler JG
Cancer Res; 2017 Sep; 77(17):4589-4601. PubMed ID: 28652252
[TBL] [Abstract][Full Text] [Related]
12. Targeting choline phospholipid metabolism: GDPD5 and GDPD6 silencing decrease breast cancer cell proliferation, migration, and invasion.
Cao MD; Cheng M; Rizwan A; Jiang L; Krishnamachary B; Bhujwalla ZM; Bathen TF; Glunde K
NMR Biomed; 2016 Aug; 29(8):1098-107. PubMed ID: 27356959
[TBL] [Abstract][Full Text] [Related]
13. Alterations of choline phospholipid metabolism in endometrial cancer are caused by choline kinase alpha overexpression and a hyperactivated deacylation pathway.
Trousil S; Lee P; Pinato DJ; Ellis JK; Dina R; Aboagye EO; Keun HC; Sharma R
Cancer Res; 2014 Dec; 74(23):6867-77. PubMed ID: 25267063
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of indomethacin-induced alterations in the choline phospholipid metabolism of breast cancer cells.
Glunde K; Jie C; Bhujwalla ZM
Neoplasia; 2006 Sep; 8(9):758-71. PubMed ID: 16984733
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of the 'organic osmolyte' glycerophosphorylcholine in isolated rat inner medullary collecting duct cells. II. Regulation by extracellular osmolality.
Bauernschmitt HG; Kinne RK
Biochim Biophys Acta; 1993 Jul; 1150(1):25-34. PubMed ID: 8392869
[TBL] [Abstract][Full Text] [Related]
16. GDPD5, a choline-generating enzyme and its novel role in tumor cell migration.
Marchan R
Arch Toxicol; 2016 Dec; 90(12):3143-3144. PubMed ID: 27696134
[No Abstract] [Full Text] [Related]
17. In vivo detection of dysregulated choline metabolism in paclitaxel-resistant ovarian cancers with proton magnetic resonance spectroscopy.
Lu J; Li Y; Li YA; Wang L; Zeng AR; Ma XL; Qiang JW
J Transl Med; 2022 Feb; 20(1):92. PubMed ID: 35168606
[TBL] [Abstract][Full Text] [Related]
18. Silencing of the glycerophosphocholine phosphodiesterase GDPD5 alters the phospholipid metabolite profile in a breast cancer model in vivo as monitored by (31) P MRS.
Wijnen JP; Jiang L; Greenwood TR; Cheng M; Döpkens M; Cao MD; Bhujwalla ZM; Krishnamachary B; Klomp DW; Glunde K
NMR Biomed; 2014 Jun; 27(6):692-9. PubMed ID: 24764256
[TBL] [Abstract][Full Text] [Related]
19. 17-allyamino-17-demethoxygeldanamycin treatment results in a magnetic resonance spectroscopy-detectable elevation in choline-containing metabolites associated with increased expression of choline transporter SLC44A1 and phospholipase A2.
Brandes AH; Ward CS; Ronen SM
Breast Cancer Res; 2010; 12(5):R84. PubMed ID: 20946630
[TBL] [Abstract][Full Text] [Related]
20. Accumulation of glycerophosphocholine (GPC) by renal cells: osmotic regulation of GPC:choline phosphodiesterase.
Zablocki K; Miller SP; Garcia-Perez A; Burg MB
Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7820-4. PubMed ID: 1652765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
